MiningStock News
Perpetua Resources wins up to US$40M Army award for tungsten exploration
Perpetua must match the Army's contribution, while later exploration phases depend on results, permitting and further funding approvals.
Williams loses NESE rehearing bid over New Jersey water permit
The denial leaves the state water-quality certification vacated, while Williams' project page still targets service in late 2027.
MiningStock News
Blue Moon Metals signs Springer tungsten mill refurbishment contract
RAM's work includes electrical upgrades and commissioning support, with mill refurbishment targeted for the fourth quarter of 2027.
Analysis
Intel agrees to acquire Classiq with quantum deal price undisclosed
The proposed hardware and software combination is expected to close in the first half of 2027, subject to regulatory approvals.
Technology
NASDAQ: MSFTMicrosoft offers voluntary buyouts across four countries
About 60,000 employees are reportedly eligible, with decisions due in early December and departures set for Dec. 31.
TechnologyAI and Autonomy
Forum Markets reports US$94.4M Fireworks AI contract over 36 months
The venture's first customer has paid an undisclosed deposit for Dallas GPU capacity expected to deploy in late December or early January.
EnergyCanada
Dongfang Electric turbine pact covers 30 units for Canadian data centres
Eco DC Solutions says capacity would exceed 2.1 GW; its Oct. 26 release omits equipment prices, binding purchase terms and delivery dates.
Health
NASDAQ: ASNDA pooled analysis of 139 treated adults showed sustained filtration gains, but long-term follow-up had no continuing placebo comparison.
Health
NASDAQ: TEMClass C certification supports continued EU access beyond the 2028 transition deadline and covers the quality management system.
Analysis
Gold trades above US$4,000 after eight-week speculative retreat
CFTC figures through Oct. 20 show managed-money net longs fell 28.2 per cent, leaving later selling outside the positioning snapshot.
Latest
Genmab reports 75% first-line response in petosemtamab colorectal study
The single-arm analysis includes unconfirmed responses and supports two enrolling Phase 3 trials; median response duration was not disclosed.
Lilly reports 14.5‑month response duration with olomorasib lung-cancer combination
The uncontrolled first-line analyses support continued development, with randomized SUNRAY-01 results expected in the first half of 2027.
Canopy Growth Corporation shareholders authorize up to 1‑for‑15 reverse split
Directors retain discretion over the ratio for common and exchangeable shares, with no effective date set in the voting disclosure.
Climb Bio reports 38% immunologic remission in kidney trial
Five of 13 patients reached immunologic remission at 12 weeks, while higher-dose cohorts and longer follow-up will guide development.
Teck Resources reports reduced capacity at Highland Valley as strike begins
USW Local 7619 represents about 1,200 workers at the B.C. copper operation, whose production loss has not been quantified.
Sterlite Technologies reports INR25.29B revenue and multiyear supply deals
A US$1.2 billion agreement spans 2026 to 2030, while a one-time tariff refund lifted the September quarter’s reported earnings.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningGold
Pinnacle Silver and Gold receives permit for 110 El Potrero drill sites
Separate mine, plant, water and infrastructure approvals remain outstanding ahead of a targeted production decision in early 2027.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
NASDAQ: MGNXFour of 16 evaluable patients responded to lorigerlimab as the company enrols a lower-dose cohort after significant treatment-related toxicity.
More in Health
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
TechnologyAI and Autonomy
Meta Platforms launches US$35B equity offerings and plans US$60B program
Common-stock cash would arrive at forward settlement, while a proposed Class C sale program has no agreement or settled terms.
Health
NASDAQ: XNCRXencor reports 45.5% confirmed response at selected kidney-cancer dose
Severe or worse treatment-related adverse events affected 72.1 per cent across expansion cohorts; FDA talks are planned for 2027.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
NASDAQ: GOOGLGoogle will fund flexible household and business resources in PJM, but the companies disclose no price or delivery schedule.
Energy
HEL: FORTUMFortum's jointly owned disposal company must complete commissioning and pass a STUK inspection before operations can begin.
Uranium
NASDAQ: NKLRThe reactor developer targets Oct. 30 for the remaining six chapters and retains its company-set 2027 deployment goal.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Psychedelics
CNSX: OPTIThe capsules are intended for three programs, including a Canadian Phase 3 PTSD trial of up to 100 people expected to begin in 2027.
Cannabis
TSE: OGIThe province estimates illegal retailers take 30 per cent of cannabis sales and proposes inspection, seizure and penalty powers for the AGCO.
Cannabis
TSE: CURAThe bid offers US$1 in cash plus 0.4013 Curaleaf shares for each Aurora share, with a Dec. 4 tender deadline.
Cannabis
TSE: CRONCash earnouts tied to 2026 and 2027 earnings add to the base price for a grower supplying nearly all 69 shops in the Dutch pilot.